Document is current
Any future updates will be listed below
-
Authors
Durant des Aulnois, Constance
Zerbib, Elie
Barberousse, Hélène
Panel, Pierre
Holway, Isabelle
Balleyguier, Corinne
Bellucci, Alexandre
Grand, Téodor
Zerbib, Jonathan
Bordonné, Corinne
Carteret, Thibault
Monseau-Thiburce, Anne-Coline
Gehin, Sophie
Petit, Erick
Ceccarelli, Marie
Tardivel, Anne-Marie
Borojeni, Shahed
Eskenazi, Sarah
Estrade, Jean-Philippe
Guillibert, François
Friederich, Ludovic
Furet, Elise
Lavoue, Vincent
Merlot, Benjamin
Pirtea, Paul
Warembourg, Sophie
Creux, Hélène
Dabi, Yohann
Bendifallah, Sofiane
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 17 September 2025
First Online: 15 December 2025
Declarations
:
: The SMO platform received approval from the French national commission for data privacy (Commission Nationale Informatique et Libertés, CNIL) and patients provided informed consent that their anonymous data may be used for research and quality improvement purposes.No additional approvals were required according to the French legislation as it was an observational study based on medical records. All methods were performed in accordance with the relevant guidelines and regulations (Declarations of Helsinki).
: Not Applicable.
: Employees of the Deuxième Avis platform: Hélène Barberousse² Experts for the Deuxième Avis platform: Pierre Panel³, Corinne Balleyguier⁵, Alexandre Bellucci⁶, Téodor Grand⁶, Jonathan Zerbib⁶, Corinne Bordonné⁷, Thibault Carteret⁸, Anne-Coline Monseau-Thiburce⁸, Sophie Gehin⁹, Erick Petit¹⁰, Marie Ceccarelli¹⁰, Anne-Marie Tardivel¹¹, Shahed Borojeni¹², Sarah Eskenazi¹³, Jean-Philippe Estrade¹⁴, François Guillibert¹⁴, Ludovic Friederich⁴, Elise Furet¹⁵, Vincent Lavoue¹⁶, Benjamin Merlot¹⁷, Paul Pirtea¹⁸, Sophie Warembourg¹⁹, Hélène Creux²⁰, Sofiane Bendifallah⁴* Authors declaring no conflicts of interest: Constance Durant des Aulnois¹, Elie Zerbib¹, Isabelle Holway⁴, Yohann Dabi¹
